RARβ2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia

Oncogene

Volumn 23, Issue 47, 2004, Pages 7846-7853

  Jones, Letetia C ^a   Tefferi, Ayalew ^b   Idos, Gregory E ^a   Kumagai, Takashi ^a   Hofmann, Wolf K ^c   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

CD34+; Myelofibrosis; RAR

Indexed keywords

CD34 ANTIGEN; MICROSATELLITE DNA; PRIMER DNA; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA;

ADULT; AGED; ALLELIC EXCLUSION; ARTICLE; CHROMOSOME 3P; CHROMOSOME DELETION; CHROMOSOME MAP; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; EPIGENETICS; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; GENE ACTIVITY; GENE EXPRESSION; HEMATOPOIESIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HYPERMETHYLATION; MALE; MOLECULAR MECHANICS; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE POLYMERASE CHAIN REACTION; RARBETA2 GENE; STEM CELL; TUMOR SUPPRESSOR GENE; BONE MARROW CELL; CHROMOSOME 3; GENETIC MARKER; GENETICS; KARYOTYPING; METAPLASIA; METHODOLOGY; NUCLEOTIDE SEQUENCE; PATHOLOGY;

BASE SEQUENCE; BONE MARROW CELLS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; DNA PRIMERS; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; KARYOTYPING; LOSS OF HETEROZYGOSITY; METAPLASIA; MICROSATELLITE REPEATS; MYELOFIBROSIS; POLYMERASE CHAIN REACTION; RECEPTORS, RETINOIC ACID;

EID: 7644238051     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207510     Document Type: Article

References (54)

1. Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M, Heisterkamp N, Stephenson JR and Groffen J. (1983). Nature, 306, 277-280.
2. Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J and Yu AL. (1997). Cancer Res., 57, 832-836.
3. Bench AJ, Cross NC, Huntly BJ, Nacheva EP and Green AR. (2001). Best Pract. Res. Clin. Haematol., 14, 531-551.
4. Breems-de Ridder MC, Lowenberg B and Jansen JH. (2000). Mol. Cell. Endocrinol., 165, 1-6.
5. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M and Minna JD. (2001). J. Natl. Cancer Inst., 93, 691-699.
6. Daly MC, Xiang RH, Buchhagen D, Hensel CH, Garcia DK, Killary AM, Minna JD and Naylor SL. (1993). Oncogene, 8, 1721-1729.
7. Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP. (2000). Nat. Genet., 25, 315-319.
8. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S and Pelicci PG. (2002). Science, 295, 1079-1082.
9. Grignani F, Valtieri M, Gabbianelli M, Gelmetti V, Botta R, Luchetti L, Masella B, Morsilli O, Pelosi E, Samoggia P, Pelicci PG and Peschle C. (2000). Blood, 96, 1531-1537.
10. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9821-9826.
11. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA and Baylin SB. (1998). Proc. Natl. Acad. Sci. USA, 95, 6870-6875.
12. Hiltunen MO, Alhonen L, Koistinaho J, Myohanen S, Paakkonen M, Marin S, Kosma VM and Janne J. (1997). Int. J. Cancer, 70, 644-648.
13. Hofmann W-K, de Vos S, Komor M, Hoelzer D, Wachsman W and Koeffler HP. (2002). Blood, 100, 3553-3560.
14. Hofmann W-K, de Vos S, Tsukasaki K, Wachsman W, Pinkus GS, Said JW and Koeffler HP. (2001). Blood, 98, 787-794.
15. Houle B, Rochette-Egly C and Bradley WE. (1993). Proc. Natl. Acad. Sci. USA, 90, 985-989.
16. Huebner K. (2001). Proc. Natl. Acad Sci. USA, 98, 14763-14765.
17. Jones PA and Baylin SB. (2002). Nat. Rev. Genet., 6, 415-428.
18. Kastner P and Chan S. (2001). Oncogene, 20, 7178-7185.
19. Kurie JM, Lotan R, Lee JJ, Lee JS, Morice RC, Liu DD, Xu XC, Khuri FR, Ro JY, Hittelman WN, Walsh GL, Roth JA, Minna JD and Hong WK. (2003). J. Natl. Cancer Inst., 95, 206-214.
20. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M and Croce CM. (2003). Cancer Res., 63, 3724-3728.
21. Labrecque J, Allan D, Chambon P, Iscove NN, Lohnes D and Hoang T. (1998). Blood, 92, 607-615.
22. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei M, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan D-SR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B and Lerman MI. (1993). Science, 260, 1317-1320.
23. Li XS, Shao ZM, Sheikh MS, Eiseman JL, Sentz D, Jetten AM, Chen JC, Dawson MI, Aisner S, Rishi AK, Gutierrez P, Schnapper L and Fontana JA. (1995). J. Cell. Physiol., 165, 449-458.
24. Lin F, Xiao D, Kolluri SK and Zhang X. (2000). Cancer Res., 60, 3271-3280.
25. Lisitsyn NA, Lisitsina NM, Dalbagni G, Barker P, Sanchez CA, Gnarra J, Linehan WM, Reid B and Wigler MH. (1995). Proc. Natl. Acad. Sci., USA, 92, 151-155.
26. Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC and Zhang X. (1996). Mol. Cell. Biol., 16, 1138-1149.
27. Martyre MC, Romquin N, Le Fousse-Kerdiles MC, Chevillard S, Benyahia B, Dupriez B, Demory JL and Bauters F. (1994). Br. J. Haematol., 88, 9-16.
28. Mesa RA, Hanson CA, Rajkumar SV, Schroeder G and Tefferi A. (2000). Blood, 96, 3374-3380.
29. Morosetti R, Park DJ, Chumakov AM, Grillier I, Shiohara M, Gombart, AF, Nakamaki T, Weinberg K and Koeffler HP. (1997). Blood, 907, 2591-2600.
30. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM and Huebner K. (1996). Cell, 84, 587-597.
31. Ohtani-Fujita N, Dryja TP, Rapaport JM, Fujita T, Matsumura S, Ozasa K, Watanabe Y, Hayashi K, Maeda K, Kinoshita S, Matsumura T, Ohnishi Y, Hotta Y, Takahashi R, Kato MV, Ishizaki K, Sasaki MS, Horsthemke B, Minoda K and Sakai T. (1997). Cancer Genet. Cytogenet., 98, 43-49.
32. Piazza F, Gurrieri C and Pandolfi PP. (2001). Oncogene, 20, 7216-7222.
33. Prowse AH, Webster AR, Richards FM, Richard S, Olschwang S, Resche F, Affara NA and Maher ER. (1997). Am. J. Hum. Genet., 60, 765-771.
34. Qiu H, Zhang W, El-Naggar AK, Lippman SM, Lin P, Lotan R and Xu XC. (1999). Am. J. Pathol., 155, 1519-1523.
35. Rowley JD. (1973). Nature, 243, 290-293.
36. Sekido Y, Ahmadian M, Wistuba II, Latif F, Bader S, Wei MH, Duh FM, Gazdar AF, Lerman MI and Minna JD. (1998). Oncogene, 16, 3151-3157.
37. Shimizu T and Takeda K. (2000). Cancer Res., 60, 4544-4549.
38. Si SP, Lee X, Tsou HC, Buchsbaum R, Tibaduiza E and Peacocke M. (1996). Exp. Cell. Res., 223, 102-111.
39. Tefferi A. (2000). N. Engl. J. Med., 342, 1255-1265.
40. Tefferi A, Mesa RA, Schroeder G, Hanson CA, Li C-Y and Dewald GW. (2001). Br. J. Haematol., 113, 763-771.
41. Thiagalingam S, Foy RL, Cheng K-H, Lee HJ, Thiagalingam A and Ponte JF. (2002). Curr. Opin. Oncol., 14, 65-72.
42. Toulouse A, Loubeau M, Morin J, Pappas JJ, Wu J and Bradley EC. (2000a). FASEB J., 14, 1224-1232.
43. Toulouse A, Morin J, Dion PA, Houle B and Bradley WE. (2000b). Lung Cancer, 28, 127-137.
44. Tyers M and Rottapel R. (1999). Proc. Natl. Acad. Sci. USA, 96, 12230-12232.
45. Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, Modrich PL, Sedwick WD and Markowitz SD. (1998). Proc. Natl. Acad. Sci. USA, 95, 8698-8702.
46. Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD and Gazdar AF. (2000). J. Natl. Cancer Inst., 92, 1303-1307.
47. Widschwendter M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendter A, Mayr A, Marth C and Zeimet AG. (1997). Cancer Res., 57, 4158-4161.
48. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon III JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF and Minna JD. (2000). Cancer Res., 60, 1949-1960.
49. Xian J, Clark KJ, Fordham R, Pannell R, Rabbitts TH and Rabbitts PH. (2001). Proc. Natl. Acad. Sci. USA, 98, 15062-15066.
50. Xie D, Hofmann W-K, Mori N, Miller CW, Hoelzer D and Koeffler HP. (2000). Leukemia, 14, 805-810.
51. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K and Lotan R. (1997a). Cancer Res., 57, 4992-4996.
52. Xu XC, Sozzi G, Lee JS, Lee JJ, Pastorino U, Pilotti S, Kurie JM, Hong WK and Lotan R. (1997b). J. Natl. Cancer Inst., 89, 624-629.
53. Zhu J, Heyworth CM, Glasow A, Huang QH, Petrie K, Lanotte M, Benoit G, Gallagher R, Waxman S, Enver T and Zelent A. (2001). Blood, 98, 2563-2567.
54. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF and Minna JD. (2001). Cancer Res., 61, 249-255.